Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- HIV-infected patients should be assessed for typical CVD risk factors, hyperlipidemia, and diabetes at entry into care
- Fasting lipid profile and screening for diabetes should be performed every 6-12 months in all patients, as well as with screening for dyslipidemia and diabetes before ART initiation, and 1-3 months after ART initiation or switches[Aberg 2014]
- Frequent blood pressure monitoring is advised
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content